Retifanlimab for anal cancer in people living with HIV: an analysis from prospective immunotherapy studies with prespecified HIV-focused endpoints☆

ESMO Gastrointestinal Oncology · Elsevier

Аннотация

Publication date: December 2026 Source: ESMO Gastrointestinal Oncology, Volume 14 Author(s): J.P. Spano, J. Capdevila, F. Van Fraeyenhove, S. Lonardi, F. Morano, M. Guillot Morales, P. Rochefort, M. Ducreux, A. Gordon, L. Evesque, E. Kim, M. Jones, X. Xu, M.C. Munteanu, A. Vozy, D.C. Gilbert

Читать у издателя →

Похожие статьи